Documentation Centre

January 18, 2021
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: further evidence fuelling the dual target concept. Eur Heart J. 2020;41:2962-2964.
Koenig W

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Inflammation, Lipids/Lipoproteins